PIER MARIA FORNASARI
2025-03-06

Physical Activity may help delay cognitive decline by modulating neurodegeneration and AD-specific tau pathologies: a study reveals

Alzheimer disease (AD), the most common cause of cognitive impairment, is characterized by β-amyloid (Aβ) plaques and tau neurofibrillary tangles, which lead to neuroinflammation, neurodegeneration, and cognitive decline. Among various interventions, physical activity (PA) is widely recommended. Numerous studies suggest that PA not only slows cognitive decline but also improves specific cognitive functions. Potential mechanisms underlying the protective

Read More

No Comments InWELLNESS
PIER MARIA FORNASARI
2025-02-26

Personalized mRNA vaccine added to standard treatment could offer new hope for pancreatic cancer patients

Adding a personalised mRNA vaccine to plain remedy might supply new hope for pancreatic cancer sufferers, a small but promising study from Memorial Sloan Kettering Cancer Center. The study adopted 16 sufferers, together with Barbara Brigham, who joined the trial after a routine scan found her early-stage pancreatic cancer. Alongside surgical procedure and chemotherapy, sufferers

Read More

No Comments InCANCER IMMUNOTHERAPY
PIER MARIA FORNASARI
2025-02-26

Magnetic microrobots remove blood clot from sheep’s femoral artery

Researchers from the University of Twente’s TechMed Centre and Radboud University Medical Centre removed blood clots using wireless magnetic robots. This innovation could revolutionise the treatment of life-threatening vascular diseases such as thrombosis. Cardiovascular diseases such as thrombosis are a major health problem worldwide. Worldwide, one in four people die each year from conditions caused

Read More

No Comments InRESEARCH
PIER MARIA FORNASARI
2025-02-26

Gene therapy in children with AIPL1-associated severe retinal dystrophy can improve vision

Researchers from the NIHR Moorfields Biomedical Research Centre and University College London have found that gene therapy improved visual acuity and preserved retinal structure in young children with AIPL1-associated severe retinal dystrophy. This is the first human trial of gene supplementation therapy targeting this condition. Retinal dystrophy caused by biallelic variants in the AIPL1 gene

Read More

No Comments InGENE THERAPY RARE DISEASES
PIER MARIA FORNASARI
2025-02-18

What are the side effects of GLP-1 medications?

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings. However, over the past few years, these medications have become popular due to their weight loss and weight management benefits. Outside of nutrition, physical activity and surgery,  Dr. Saundra Nguyen, assistant professor of internal medicine at Baylor College of Medicine, explaining

Read More

No Comments InWELLNESS
PIER MARIA FORNASARI
2025-02-17

Blood test paves the way for better heart attack prevention

A simple scoring system could revolutionise how doctors prevent heart attacks and strokes by identifying patients most likely to benefit from preventive medications, according to a new study.   The breakthrough test, called the TRIPLE Score, (Thrombotic Reactivity Indicator using Platelet GPVI, CD36 [cluster of differentiation 36] Expression, and age) measures specific proteins on blood platelets

Read More

No Comments InWELLNESS
PIER MARIA FORNASARI
2025-02-15

Epidural steroid injections for chronic back pain: An AAN systematic review

The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and disability for people with certain kinds of chronic back pain. The systematic review is published on February 12, 2025, online in Neurology®. It updates

Read More

No Comments InWELLNESS